Zhejiang Xinguang Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300519.SZ

Zhejiang Xinguang Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.00

Zhejiang Xinguang Pharmaceutical Co., Ltd. Debt to Equity Ratio is 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.00, a 0.00% change year over year.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.00, a 0.00% change year over year.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.00, a -100.00% change year over year.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.00, a -5.81% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
Shenzhen Stock Exchange: 300519.SZ

Zhejiang Xinguang Pharmaceutical Co., Ltd.

CEO Mr. Yue Jun Wang
IPO Date June 24, 2016
Location China
Headquarters No. 25, Huancheng West Road
Employees 315
Sector Health Care
Industries
Description

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health foods. The company offers pharmaceutical products in the areas of cardiovascular and cerebrovascular diseases, and traumatic diseases, covering the aspects of respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. It also can produce 6 dosage forms with 49 approval numbers for drug production and 2 approval numbers for health food. It offers its products in the form of tablets, granules, syrups, powders, hard capsules, and oral solutions, as well as mixtures, including oral liquids. Zhejiang Xinguang Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Shengzhou, China.

StockViz Staff

January 16, 2025

Any question? Send us an email